(Q53474628)

English

The pharmacokinetics, efficacy, safety, and ease of use of a novel portable metered-dose cannabis inhaler in patients with chronic neuropathic pain: a phase 1a study.

scientific article published on 13 August 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 May 2018

http://europepmc.org/abstract/MED/25118789

The pharmacokinetics, efficacy, safety, and ease of use of a novel portable metered-dose cannabis inhaler in patients with chronic neuropathic pain: a phase 1a study. (English)

1 reference

Europe PubMed Central

14 May 2018

http://europepmc.org/abstract/MED/25118789

neuropathic pain

0 references

0 references

chronic neuropathic pain

0 references

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Elon Eisenberg

1

1 reference

Europe PubMed Central

14 May 2018

http://europepmc.org/abstract/MED/25118789

Miri Ogintz

2

1 reference

Europe PubMed Central

14 May 2018

http://europepmc.org/abstract/MED/25118789

Shlomo Almog

3

1 reference

Europe PubMed Central

14 May 2018

http://europepmc.org/abstract/MED/25118789

publication date

13 August 2014

1 reference

Europe PubMed Central

14 May 2018

http://europepmc.org/abstract/MED/25118789

Journal of Pain and Palliative Care Pharmacotherapy

1 reference

Europe PubMed Central

14 May 2018

http://europepmc.org/abstract/MED/25118789

28

1 reference

Europe PubMed Central

14 May 2018

http://europepmc.org/abstract/MED/25118789

3

1 reference

Europe PubMed Central

14 May 2018

http://europepmc.org/abstract/MED/25118789

216-225

1 reference

Europe PubMed Central

14 May 2018

http://europepmc.org/abstract/MED/25118789

Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2014.941130

21 January 2018

Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2014.941130

21 January 2018

Multiple sclerosis and extract of cannabis: results of the MUSEC trial.

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2014.941130

21 January 2018

Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2014.941130

21 January 2018

Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2014.941130

21 January 2018

Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2014.941130

21 January 2018

A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2014.941130

21 January 2018

Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2014.941130

21 January 2018

A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2014.941130

21 January 2018

Low-dose vaporized cannabis significantly improves neuropathic pain

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2014.941130

21 January 2018

Smoked cannabis for chronic neuropathic pain: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2014.941130

21 January 2018

The medicinal use of cannabis and cannabinoids--an international cross-sectional survey on administration forms

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2014.941130

21 January 2018

Plasma delta-9-tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2014.941130

21 January 2018

Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2014.941130

21 January 2018

Pharmacokinetics and pharmacodynamics of cannabinoids

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2014.941130

21 January 2018

Human cannabinoid pharmacokinetics

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2014.941130

21 January 2018

Cannabis “Vaporization”

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2014.941130

21 January 2018

Cannabis Vaporizer Combines Efficient Delivery of THC with Effective Suppression of Pyrolytic Compounds

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2014.941130

21 January 2018

Vaporization as a smokeless cannabis delivery system: a pilot study

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2014.941130

21 January 2018

Cannabinoid receptor 1 binding activity and quantitative analysis of Cannabis sativa L. smoke and vapor.

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2014.941130

21 January 2018

Cannabis smoke condensate III: the cannabinoid content of vaporised Cannabis sativa

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2014.941130

21 January 2018

The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2014.941130

21 January 2018

Delta-9-tetrahydrocannabinol (THC) serum concentrations and pharmacological effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg THC.

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2014.941130

21 January 2018

Disposition of smoked cannabis with high Δ(9)-tetrahydrocannabinol content: a kinetic model

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2014.941130

21 January 2018

Characterization of the absorption phase of marijuana smoking

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2014.941130

21 January 2018

Psychomotor performance, subjective and physiological effects and whole blood Δ⁹-tetrahydrocannabinol concentrations in heavy, chronic cannabis smokers following acute smoked cannabis

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2014.941130

21 January 2018

Cannabinoid-opioid interaction in chronic pain

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2014.941130

21 January 2018

Pharmacokinetic and pharmacodynamic profile of supratherapeutic oral doses of Δ(9) -THC in cannabis users

1 reference

https://api.crossref.org/works/10.3109%2F15360288.2014.941130

21 January 2018

Identifiers

10.3109/15360288.2014.941130

1 reference

Europe PubMed Central

14 May 2018

http://europepmc.org/abstract/MED/25118789

1 reference

Europe PubMed Central

14 May 2018

http://europepmc.org/abstract/MED/25118789

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53474628&oldid=2144459611"